How effective is serpatinib for hyperthyroidism?

Selpercatinib (Selpercatinib), as a highly selective RET oral inhibitor, is mainly used to treat cancers carrying RET gene fusions or mutations, such as non-small cell lung cancer (NSCLC) and thyroid cancer. However, serpatinib is not a first-line treatment for hyperthyroidism (hyperthyroidism), an endocrine disease.

Serpatinib prevents the growth and spread of cancer cells by inhibiting the activity ofRET protein. RET gene fusions or mutations play a driving role in certain cancers, and serpatinib is designed to target these specific gene mutations. In clinical trials, serpatinib has demonstrated significant therapeutic effects in patients with RET fusion-positive NSCLC and patients with RET-mutant medullary thyroid cancer who require systemic therapy.

Hyperthyroidism is a group of common endocrine diseases caused by excessive secretion of thyroid hormones caused by various reasons. The principle of treatment is mainly to reduce the synthesis or release of thyroid hormone through drugs, surgery or radioactive iodine, thereby controlling symptoms and restoring normal thyroid function.

Serpatinib mainly targets cancers with RET gene fusions or mutations rather than the endocrine disease of hyperthyroidism. Therefore, from the perspective of indications, serpatinib is not a recommended treatment for hyperthyroidism.

Although serpatinib has shown certain efficacy in cancer treatment, it is also accompanied by a series of potential side effects, such as liver toxicity, hypertension, QT interval prolongation, etc. For people with hyperthyroidism, these side effects may worsen the condition or cause new health problems.

In summary, serpatinib is not a recommended treatment for hyperthyroidism. For patients with hyperthyroidism, they should follow the doctor's advice and choose a treatment method suitable for their condition, such as antithyroid drugs, surgery or radioactive iodine therapy. At the same time, maintain good living and dietary habits, and conduct regular examinations and evaluations to ensure that the condition is effectively controlled.

References:

https://www.nejm.org/doi/full/10.1056/NEJMoa2005651